سعر اورينشيا 125مجم سرنجات معبئة مسبقا 2022

Abatacept 125 mg solution for subcutaneous injection in pre-filled syringe by Bristol-Myers Squibb (distributed by United Company for Trading & Distribution, Egypt).

• Moderately to severely active rheumatoid arthritis in adults.DailyMed (U.S. National Library of Medicine)
• Moderately to severely active polyarticular juvenile idiopathic arthritis (2 years and older).DailyMed (U.S. National Library of Medicine)
• Active psoriatic arthritis (2 years and older).DailyMed (U.S. National Library of Medicine)

• Most common in RA (>=10%): headache, upper respiratory tract infection, nasopharyngitis, nausea.International label, same product · DailyMed (U.S. National Library of Medicine)

• None (US label).International label, same product · DailyMed (U.S. National Library of Medicine)

• Concomitant use with TNF antagonists, other biologics or JAK inhibitors increases infection risk and is not recommended.International label, same product · DailyMed (U.S. National Library of Medicine)
• Hypersensitivity and anaphylaxis have occurred.International label, same product · DailyMed (U.S. National Library of Medicine)
• Serious infections reported; screen for latent TB and viral hepatitis before starting; discontinue if a serious infection develops.International label, same product · DailyMed (U.S. National Library of Medicine)

• Human data insufficient to inform risk; no fetal malformations in rats and rabbits, but immune function was altered in rat offspring; consider live-vaccine timing in infants exposed in utero.International label, same product · DailyMed (U.S. National Library of Medicine)
• No information on presence in human milk; abatacept was present in the milk of lactating rats.International label, same product · DailyMed (U.S. National Library of Medicine)

English text not available for this section.